Recombinant antibodies are one of the fastest-growing classes of biotherapeutics in the past two decades. Antibody-dependent cellular cytotoxicity (ADCC) exhibits certain mechanisms of action to treat certain tumors. ADCC enhancement is, now, a very promising approach to improve the efficacy of therapeutic antibody drugs. Creative Biolabs provides a comprehensive list of therapeutic antibodies with enhanced ADCC property to help accelerate your research process.